Effects of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction patients with chronic obstructive pulmonary disease in EMPHASIS-HF and RALES

MLA

Pardeep S. Jhund, et al. “Effects of Mineralocorticoid Receptor Antagonists in Heart Failure with Reduced Ejection Fraction Patients with Chronic Obstructive Pulmonary Disease in EMPHASIS-HF and RALES.” European Journal of Heart Failure, vol. 24, no. 3, Mar. 2022, pp. 529–38. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....688aa2871b2b968d73eff4f1a160228a&authtype=sso&custid=ns315887.

APA

Pardeep S. Jhund, Su E. Yeoh, Dirk J. van Veldhuisen, Bertram Pitt, Karl Swedberg, John J.V. McMurray, João Pedro Ferreira, Faiez Zannad, Matteo Serenelli, & Pooja Dewan. (2022). Effects of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction patients with chronic obstructive pulmonary disease in EMPHASIS-HF and RALES. European Journal of Heart Failure, 24(3), 529–538.

Chicago

Pardeep S. Jhund, Su E. Yeoh, Dirk J. van Veldhuisen, Bertram Pitt, Karl Swedberg, John J.V. McMurray, João Pedro Ferreira, Faiez Zannad, Matteo Serenelli, and Pooja Dewan. 2022. “Effects of Mineralocorticoid Receptor Antagonists in Heart Failure with Reduced Ejection Fraction Patients with Chronic Obstructive Pulmonary Disease in EMPHASIS-HF and RALES.” European Journal of Heart Failure 24 (3): 529–38. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....688aa2871b2b968d73eff4f1a160228a&authtype=sso&custid=ns315887.